Spectrum Pharmaceuticals Inc
SPPIDelisted Aug 1, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000831547
Spectrum Pharmaceuticals Inc was delisted on Aug 1, 2023; its insiders filed their last Form 4 on Aug 1, 2023; 78 institutions reported holding it in 13F filings for Q2 2023, worth $56.5M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 78
- Q2 2023, +9 vs. previous quarter
- 13F value
- $56.5M
- Reported value at the end of Q2 2023
- Superinvestors holding
- 0
- At the end of Q2 2023
Superinvestors holding SPPI, Q2 2023
No superinvestor reported holding SPPI at the end of Q2 2023.
Latest insider trades
Open-market purchases and sales by Spectrum Pharmaceuticals Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 30, 2023 (view filing) | May 26 | 4 days | Brennan NoraCFO | SSaleCommon Stock, $0.001 par value | −32.4K | $1.10 | −$35.6K | −5.4%567.8K after | |
| Mar 17, 2023 (view filing) | Mar 14-15 | 3 daysLate | McGahan Keith MChief Legal Officer | SSaleCommon Stock, $0.001 par value | −42.9K | $0.8073 | −$34.7K | −18.5%189.3K after | 2 lots |
| Mar 17, 2023 (view filing) | Mar 14-15 | 3 daysLate | Riga Thomas JCEO & President | SSaleCommon Stock, $0.001 par value | −49.5K | $0.8073 | −$40.0K | −9.5%472.4K after | 2 lots |
| Feb 24, 2023 (view filing) | Feb 22-23 | 2 days | McGahan Keith MChief Legal Officer | SSaleCommon Stock, $0.001 par value | −30.4K | $0.7661 | −$23.3K | −4.7%618.3K after | 2 lots |
| Feb 24, 2023 (view filing) | Feb 22 | 2 days | Riga Thomas JCEO & President | SSaleCommon Stock, $0.001 par value | −37.0K | $0.7661 | −$28.4K | −2.0%1.84M after | 2 lots |
| Feb 1, 2023 (view filing) | Jan 30-31 | 2 days | McGahan Keith MChief Legal Officer | SSaleCommon Stock, $0.001 par value | −67.2K | $0.5889 | −$39.5K | −9.4%645.9K after | 2 lots |
| Feb 1, 2023 (view filing) | Jan 30-31 | 2 days | Riga Thomas JCEO & President | SSaleCommon Stock, $0.001 par value | −176.8K | $0.6129 | −$108.4K | −8.5%1.90M after | 2 lots |
| Jan 5, 2023 (view filing)7:50 PM ET | Jan 3 | 2 days | Riga Thomas JCEO & President | SSaleCommon Stock, $0.001 par value | −23.9K | $0.382 | −$9.14K | −2.0%1.19M after | |
| Dec 2, 2022 (view filing)8:17 PM ET | Nov 30 | 2 days | Vacirca Jeff LDirector | PPurchaseCommon Stock, $0.001 par value | +50.0K | $0.45 | +$22.5K | +22.7%270.2K after | |
| Jun 23, 2022 (view filing) | Jun 22-23 | 1 day | Lebel FrancoisChief Medical Officer | SSaleCommon Stock, $0.001 par value | −12.8K | $0.8257 | −$10.5K | −1.9%644.8K after | 2 lots |
Top 10 13F holders, Q2 2023
The largest institutional positions in Spectrum Pharmaceuticals Inc at the end of Q2 2023; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 20,000,000 | $19.2M | 0.48% | +3,300,000+19.8% | Added |
| Vanguard Group Inc | 8,580,357 | $8.24M | 0.00% | −197,313−2.2% | Reduced |
| Kennedy Capital Management, Inc. | 4,881,037 | $4.69M | 0.11% | +4,881,037 | New |
| BlackRock Inc. | 3,482,697 | $3.34M | 0.00% | +34,219+1.0% | Added |
| Acadian Asset Management LLC | 2,906,092 | $2.79M | 0.01% | −806,319−21.7% | Reduced |
| Ergoteles LLC | 2,329,817 | $2.24M | 0.11% | +2,329,817 | New |
| Geode Capital Management, LLC | 1,783,701 | $1.71M | 0.00% | +26,264+1.5% | Added |
| Renaissance Technologies LLC | 1,417,567 | $1.36M | 0.00% | +450,167+46.5% | Added |
| New York Life Investment Management LLC | 1,378,422 | $1.32M | 0.01% | +1,378,422 | New |
| Morgan Stanley | 1,107,825 | $1.06M | 0.00% | −38,294−3.3% | Reduced |